On-demand webcast reviews the tools organizations should consider purchasing for virtual lab management and highlights the VMLogix virtual lab solution
Santa Clara, Calif. – May 18, 2010 – VMLogix, Inc. , a provider of virtual machine management solutions designed for software companies and IT organizations, today announced that the webcast, “Hybrid Clouds, One Lab: How do I Justify the Purchase?” – part of the voke, inc. Virtual Lab Management webcast series – is now available to view on the voke website. Join Sameer Dholakia, CEO of VMLogix, for a demonstration and discussion of the VMLogix LabManager solution. Explore the use cases and benefits of virtual lab technology and learn how to justify the purchase within your organization. You can register and view the joint VMLogix and voke webcast here .
“voke recently surveyed 100 organizations, and found that survey participants clearly and quickly identified ROI from the use of virtual lab technology," said Theresa Lanowitz, founder, voke, inc. "Our survey results found the VMLogix solution gaining in adoption due to its ease of use, broad hypervisor support and customizable user interface. These attributes have proven to be critical in the expansion of VMLogix beyond the test lab and into areas such as training, sales and support. voke sees virtual lab technology in use in a diverse range of organizations including small businesses, the technology sector and large enterprises. voke’s webcast series is designed to help users gain a greater understanding of the market and drive awareness of this transformational technology that delivers immediate ROI.”
"An increasing number of organizations are moving beyond just server virtualization and are seriously considering virtual lab management for their software development and testing needs as well as a number of other use cases including software support, training, sales demos and even the management of their on-premise private clouds,” said Sameer Dholakia, CEO of VMLogix. “This webcast series is a great educational resource for learning about virtual lab management, what it can offer your organization and what tools – including our LabManager solution – are out there.”
For more information and to see all the available webcasts in the voke Virtual Lab Management series, go here . For more information on VMLogix and its solutions, visit http://www.vmlogix.com/VMLogix/Products/.
VMLogix LabManager is a powerful virtual lab management solution that enables IT administrators to use any of the leading virtualization platforms from Citrix, Microsoft, Red Hat or VMware to consolidate virtual lab infrastructures. LabManager allows end users to gain access to lab resources in a policy controlled, automated and self-service manner, which can dramatically reduce the manual effort, time and IT resources required to develop and maintain an organization’s required environments by using comprehensive automation capabilities, advanced team management and seamless integrations with leading solutions.
VMLogix provides virtual machine management solutions designed for
software companies and IT organizations to use any of the leading
virtualization platforms for consolidating test lab infrastructures,
automating the software build and test process, and for managing the
staging and delivery of applications into production. Companies
worldwide use VMLogix technology to deliver software more quickly,
cost-effectively and reliably than with any other solution on the
market. VMLogix has partnerships with the industry's most established
technology companies including Citrix, IBM, Microsoft and VMware.
VMLogix is a privately-held company headquartered in Santa Clara,
California. The company has received funding from Bain Capital Ventures
and Trilogy. For more information on VMLogix, visit www.vmlogix.com
VMLogix and VMLogix LabManager are trademarks of VMLogix, Inc.
Citrix® and XenServer® are trademarks of Citrix Systems, Inc. and/or one
or more of its subsidiaries, and may be registered in the U.S. Patent
and Trademark Office and in other countries. All other trademarks and
registered trademarks are property of their respective owners.